Compared with controls, T2DM rats showed higher levels of IL-6 and p-IKBα, while C3aRA treatment significantly decreased IL-6 and p-IKBα levels in T2DM rats. This evidence concerns the gene NFKBIA and type 2 diabetes mellitus.